Zelluna ASA (ZLNA)

Currency in NOK
14.34
-0.14(-0.99%)
Real-time Data·
ZLNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ZLNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.8514.50
52 wk Range
12.0034.20
Key Statistics
Prev. Close
14.48
Open
14.5
Day's Range
13.85-14.5
52 wk Range
12-34.2
Volume
969
Average Volume (3m)
7.97K
1-Year Change
-45.63%
Book Value / Share
6.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZLNA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Zelluna ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Zelluna ASA Company Profile

As of March 3, 2025, Ultimovacs ASA was acquired by Zelluna Immunotherapy AS in a reverse merger transaction. Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.

Zelluna ASA Earnings Call Summary for Q2/2025

  • Zelluna's cash position at 76M NOK, runway through Q2 2026; Q2 EBIT -38M NOK, YTD EBIT -68M NOK
  • Advancing ZEMA four one cell therapy platform for multiple cancers; clinical trial application planned for H2 2025
  • Stock rose 1.85% post-earnings to $1.34, below 52-week high of $2.19; market cap $3.63M
  • First human clinical data expected in 2026; expanding pipeline for solid tumors
  • CEO optimistic about company's unique position in cell therapy space despite challenging environment
Last Updated: 20/08/2025, 08:50
Read Full Transcript

Compare ZLNA to Peers and Sector

Metrics to compare
ZLNA
Peers
Sector
Relationship
P/E Ratio
−3.0x−1.0x−0.6x
PEG Ratio
-−0.020.00
Price/Book
2.4x0.7x2.6x
Price / LTM Sales
5,660.1x4.5x3.3x
Upside (Analyst Target)
-246.9%38.7%
Fair Value Upside
Unlock42.1%5.1%Unlock

Earnings

Latest Release
Aug 20, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ZLNA Income Statement

FAQ

What Stock Exchange Does Zelluna Trade On?

Zelluna is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for Zelluna?

The stock symbol for Zelluna is "ZLNA."

What Is the Zelluna Market Cap?

As of today, Zelluna market cap is 37.42M.

What Is Zelluna's Earnings Per Share (TTM)?

The Zelluna EPS (TTM) is -58.44.

When Is the Next Zelluna Earnings Date?

Zelluna will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is ZLNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zelluna Stock Split?

Zelluna has split 1 times.

How Many Employees Does Zelluna Have?

Zelluna has 12 employees.

What is the current trading status of Zelluna (ZLNA)?

As of 28 Aug 2025, Zelluna (ZLNA) is trading at a price of 14.34, with a previous close of 14.48. The stock has fluctuated within a day range of 13.85 to 14.50, while its 52-week range spans from 12.00 to 34.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.